Aequus Pharmaceuticals (AQSZF) is a growing specialty pharmaceutical company with an increasing pipeline of commercial products in ophthalmology and transplant, and a development stage pipeline in neurology and psychiatry. If you are interested to learn more about the business strategy and product portfolio please find more information in my introductory article from 14th March 2019. The introductory article describes the path to breakeven and the events we expect during 2019. In today's article, I will follow-up and summarize the progress in order to verify the investment opportunity.
Recap of Investment Opportunity
The thesis